I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Real-life comparison of afatinib and erlotinib in non-small..:
Selcukbiricik, Fatih
;
Turkoz, Fatma Paksoy
;
Gursoy, Pinar
...
Journal Of Cancer Research And Clinical Oncology. , 2022
Link:
https://hdl.handle.net/11499/46751
RT Journal T1
Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study
UL https://suche.suub.uni-bremen.de/peid=base-ftpamukkaleuniv:oai:gcris.pau.edu.tr:11499_46751&Exemplar=1&LAN=DE A1 Selcukbiricik, Fatih A1 Turkoz, Fatma Paksoy A1 Gursoy, Pinar A1 Tatli, Ali Murat A1 Erdem, Dilek A1 Goker, Erdem A1 Celik, Emir A1 Demirci, Nebi Serkan A1 Sakin, Abdullah A1 Atci, Muhammed Mustafa A1 Bayram, Ertugrul A1 Telli, Tugba Akin A1 Bilgin, Burak A1 Bilici, Ahmet A1 Akangunduz, Baran A1 Balli, Sevinc A1 Demirkazik, Ahmet A1 Menekse, Serkan A1 Cavdar, Eyyup A1 Ozturk, Akin A1 Bekmez, Esma Turkmen A1 Turhal, Serdal A1 Kilickap, Sadettin A1 Yildirim, Hasan Cagri A1 Oyan, Basak A1 Aksoy, Asude A1 Kut, Engin A1 Katgi, Nuran A1 Sakalar, Teoman A1 Akyol, Murat A1 Ellez, Halil Ibrahim A1 Topcu, Atakan A1 Erdogan, Atike Pinar A1 Pilanci, Kezban Nur A1 Hedem, Engin A1 Arak, Haci A1 Akdeniz, Nadiye A1 Alan, Ozkan A1 Yapar, Burcu A1 Nart, Deniz A1 Yumuk, Perran Fulden PB Springer YR 2022 K1 Exon 18 K1 Exon 20 K1 Erlotinib K1 Afatinib K1 NSCLC K1 Growth-Factor Receptor K1 Tyrosine Kinase Inhibitor K1 1st-Line Treatment K1 Open-Label K1 Multicenter K1 Efficacy K1 Chemotherapy JF Journal Of Cancer Research And Clinical Oncology LK http://dx.doi.org/https://hdl.handle.net/11499/46751 DO https://hdl.handle.net/11499/46751 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)